NO2011024I2 - Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen - Google Patents

Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen

Info

Publication number: NO2011024I2
Authority: NO; Norway
Prior art keywords: deposited; virus; strain; spdv; ecacc
Prior art date: 1994-10-18

Application number

NO2011024C

Other languages

English (en)

Other versions

NO2011024I1 (no

Original Assignee

Intervet Int Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-18

Filing date

2011-10-28

Publication date

2015-09-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2011024(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-18 Priority claimed from GB9420956A external-priority patent/GB9420956D0/en

1995-04-28 Priority claimed from GBGB9508704.5A external-priority patent/GB9508704D0/en

1995-05-10 Priority claimed from GBGB9509425.6A external-priority patent/GB9509425D0/en

2011-10-28 Application filed by Intervet Int Bv filed Critical Intervet Int Bv

2011-11-14 Publication of NO2011024I1 publication Critical patent/NO2011024I1/no

2015-09-07 Publication of NO2011024I2 publication Critical patent/NO2011024I2/no

Links

241000700605 Viruses Species 0.000 title abstract 6
208000016222 Pancreatic disease Diseases 0.000 title abstract 2
241000972773 Aulopiformes Species 0.000 title 1
235000019515 salmon Nutrition 0.000 title 1
241000251468 Actinopterygii Species 0.000 abstract 1
241000277263 Salmo Species 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
231100000676 disease causative agent Toxicity 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
235000019688 fish Nutrition 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Oncology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Tropical Medicine & Parasitology (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Mycology (AREA)
Cell Biology (AREA)

NO2011024C 1994-10-18 2011-10-28 Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen NO2011024I2 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9420956A GB9420956D0 (en)	1994-10-18	1994-10-18	Virus
GBGB9508704.5A GB9508704D0 (en)	1995-04-28	1995-04-28	Virus
GBGB9509425.6A GB9509425D0 (en)	1995-05-10	1995-05-10	"Virus"

Publications (2)

Publication Number	Publication Date
NO2011024I1 NO2011024I1 (no)	2011-11-14
NO2011024I2 true NO2011024I2 (no)	2015-09-07

Family

ID=27267435

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19954135A NO317547B1 (no)	1994-10-18	1995-10-17	Fiskebukspyttkjertel-sykdomsvirus, fremgangsmate for diagnostisering av sykdom og for isolering av virus, samt vaksine og diagnostisk reagens.
NO2011024C NO2011024I2 (no)	1994-10-18	2011-10-28	Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO19954135A NO317547B1 (no)	1994-10-18	1995-10-17	Fiskebukspyttkjertel-sykdomsvirus, fremgangsmate for diagnostisering av sykdom og for isolering av virus, samt vaksine og diagnostisk reagens.

Country Status (9)

Country	Link
US (2)	US5939073A (no)
EP (1)	EP0712926B1 (no)
JP (1)	JP3676449B2 (no)
AT (1)	ATE251667T1 (no)
CA (1)	CA2160764C (no)
DE (1)	DE69531891D1 (no)
DK (1)	DK0712926T3 (no)
NO (2)	NO317547B1 (no)
PT (1)	PT712926E (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0626635B1 (en) *	1993-05-24	2003-03-05	Sun Microsystems, Inc.	Improved graphical user interface with method for interfacing to remote devices
WO1999058639A2 (en) *	1998-05-08	1999-11-18	Akzo Nobel N.V.	Structural proteins of fish pancreatic disease virus and uses thereof
CA2393895A1 (en) *	2001-07-17	2003-01-17	University Of Prince Edward Island	Serological test for isav in fish
US6936256B2 (en) *	2001-08-10	2005-08-30	University Of Maryland Biotechnology Institute	Sub-unit vaccine for infectious pancreatic necrosis virus
AU2004279610B2 (en)	2003-10-07	2010-02-25	Ingrid Dheur	Piscirickettsia salmonis antigens and use thereof
DK179025B1 (da)	2005-09-16	2017-08-28	Intervet Int Bv	Fiskevaccine
NZ578541A (en)	2006-12-22	2012-04-27	Soluciones Biotecnologicas Innovacion Ltda	Dna vaccines for fish
AU2008337440B2 (en)	2007-12-19	2013-05-02	Intervet International B.V.	Vaccine antigens from Piscirickettsia salmonis
NO346489B1 (no) *	2008-02-08	2022-09-05	Pharmaq As	Anvendelse av inaktivert SAV i fremstilling av en vaksine.
NO333242B1 (no) *	2008-02-08	2013-04-15	Pharmaq As	Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus
US9139618B2 (en)	2010-12-29	2015-09-22	Intervet Inc.	Salmonid alphavirus protein E2
EP2688587B2 (en)	2011-03-25	2023-08-16	Intervet International B.V.	Salmonid alphavirus vaccine
EP3037823A1 (en)	2014-12-22	2016-06-29	BioMar Group A/S	Method for determining pathological tissue damage and diagnosing infectious disease in fish
KR102163242B1 (ko) *	2018-06-05	2020-10-08	전남대학교산학협력단	무지개송어의 면역글로불린 m에 특이적인 단클론항체 및 이의 용도
NO344938B1 (en)	2018-12-13	2020-07-20	Patogen As	Pancreas Disease Virus Markers
CN113122510A (zh) *	2021-04-12	2021-07-16	中国水产科学研究院黑龙江水产研究所	一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5165925A (en) *	1989-05-02	1992-11-24	State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University	Vaccine for immunizing fish against infectious pancreatic necrosis virus

1995
- 1995-10-13 DK DK95202771T patent/DK0712926T3/da active
- 1995-10-13 AT AT95202771T patent/ATE251667T1/de active
- 1995-10-13 PT PT95202771T patent/PT712926E/pt unknown
- 1995-10-13 DE DE69531891T patent/DE69531891D1/de not_active Expired - Lifetime
- 1995-10-13 EP EP95202771A patent/EP0712926B1/en not_active Expired - Lifetime
- 1995-10-17 CA CA002160764A patent/CA2160764C/en not_active Expired - Lifetime
- 1995-10-17 NO NO19954135A patent/NO317547B1/no not_active IP Right Cessation
- 1995-10-18 JP JP27017295A patent/JP3676449B2/ja not_active Expired - Lifetime
- 1995-10-18 US US08/544,681 patent/US5939073A/en not_active Expired - Lifetime
1997
- 1997-05-08 US US08/854,057 patent/US5914260A/en not_active Expired - Lifetime
2011
- 2011-10-28 NO NO2011024C patent/NO2011024I2/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0712926A3 (no)	1996-07-03
JP3676449B2 (ja)	2005-07-27
JPH08228770A (ja)	1996-09-10
EP0712926A2 (en)	1996-05-22
NO954135D0 (no)	1995-10-17
NO317547B1 (no)	2004-11-15
CA2160764C (en)	2002-09-03
CA2160764A1 (en)	1996-04-19
ATE251667T1 (de)	2003-10-15
NO2011024I1 (no)	2011-11-14
DE69531891D1 (de)	2003-11-13
PT712926E (pt)	2004-02-27
US5914260A (en)	1999-06-22
EP0712926B1 (en)	2003-10-08
NO954135L (no)	1996-04-19
DK0712926T3 (da)	2004-02-09
US5939073A (en)	1999-08-17

Legal Events

Date	Code	Title	Description
2015-09-07	MK1K	Patent expired

Publication	Publication Date	Title
NO2011024I1 (no)	2011-11-14	Laksepankreassykdomsvirus (SPDV) stamme F93-125; deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen
Hulst et al.	2000	Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein Erns
DE69637914D1 (de)	2009-06-10	Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
DE69536039D1 (de)	2010-02-11	Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
DK0784483T3 (da)	2001-03-26	Præparat indeholdende et rekombinant virus, der udtrykker et antigen, og et rekombinant virus, der udtrykker et immunstimul
NO329875B1 (no)	2011-01-17	Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
DK33190A (da)	1990-03-28	Hiv-3 retrovirus og anvendelse heraf
CA2102036A1 (en)	1994-05-01	Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus
NZ503039A (en)	2002-09-27	Recombinant porcine adenovirus vector
EP2204179A3 (en)	2010-12-22	Modified Vaccinia Virus Ankara for the vaccination of neonates
ATE241014T2 (de)	2003-06-15	Hiv-2 varianten
CA2186044A1 (en)	1995-09-28	Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
US6410032B1 (en)	2002-06-25	Attenuated forms of bovine viral diarrhea virus
Daly et al.	1985	Serological heterogeneity of recent isolates of Yersinia ruckeri from Ontario and British Columbia
CA2248182A1 (en)	1997-09-04	Porcine reproductive and respiratory syndrome vaccine
IE780360L (en)	1978-09-04	Vaccine against "egg drop disease".
PT868522E (pt)	2003-08-29	Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao
NO20005608D0 (no)	2000-11-07	Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
Amadori et al.	1995	Role of a distinct population of bovine γδ T cells in the immune response to viral agents
CA2167274A1 (en)	1995-02-16	Inactivated respiratory syncytial viral vaccines
AU5315790A (en)	1990-10-18	Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by p. falciparum at the sporozoite stage and in the hepatocytes
WO2010135054A2 (en)	2010-11-25	Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine
Ashraf	2005	Studies on infectious bursal disease virus
AR248047A1 (es)	1995-05-31	Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
SE9600436D0 (sv)	1996-02-06	Vaccine against hantavirus